(Q45762625)

15 December 2017

title

Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus (English)

1 reference

15 December 2017

main subject

immunization

0 references

author

Françoise Barré-Sinoussi

object named as

Barré-Sinoussi F

1 reference

15 December 2017

Meignier B

1 reference

15 December 2017

author name string

Girard M

1 reference

15 December 2017

van der Ryst E

1 reference

15 December 2017

Nara P

1 reference

15 December 2017

Tartaglia J

1 reference

15 December 2017

Paoletti E

1 reference

15 December 2017

Blondeau C

1 reference

15 December 2017

Jennings M

1 reference

15 December 2017

Verrier F

1 reference

15 December 2017

Fultz PN

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

15 December 2017

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

15 December 2017

volume

232

1 reference

15 December 2017

issue

1 reference

15 December 2017

page(s)

98-104

1 reference

15 December 2017

Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Measurement of avidity of specific IgG for verification of recent primary rubella

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Immunisation with canarypox virus expressing rabies glycoprotein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Measuring vaccine-induced HIV neutralization: report of a workshop.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Characterisation of a series of human immunodeficiency virus isolates derived sequentially from a single patient

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Superinfection of a chimpanzee with a second strain of human immunodeficiency virus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Vaccine protection against HIV-2 infection in cynomolgus monkeys

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Potential use of non-replicating vectors as recombinant vaccines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1006/VIRO.1997.8560

Identifiers

DOI

10.1006/VIRO.1997.8560

1 reference

15 December 2017

1 reference

15 December 2017